Mustang Bio, Inc. (MBIO)
Develops cell therapies to treat hard-to-cure cancers and autoimmune diseases.
$0.63+0.12%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-57.0%
The outlook
MBIO trades near its 52-week lows at $0.63, well below both its 50- and 200-day moving averages. Analyst coverage is thin for the stock. The overall sentiment reflected in available data leans decidedly bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Market cap
$4.8M
52-wk high
$1.94
52-wk low
$0.53
50-day avg
$0.67
200-day avg
$0.95
Trailing P/E
—